Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Capital Leases (2021 - 2024)

Core Scientific has reported Capital Leases over the past 4 years, most recently at $3000.0 for Q4 2024.

  • Quarterly results put Capital Leases at $3000.0 for Q4 2024, down 99.99% from a year ago — trailing twelve months through Dec 2024 was $3000.0 (down 99.99% YoY), and the annual figure for FY2024 was $3000.0, down 99.99%.
  • Capital Leases reached $3000.0 in Q4 2024 per CORZ's latest filing, down from $4000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $62.1 million in Q4 2021 and bottomed at $3000.0 in Q4 2024.
  • Median Capital Leases over the past 4 years was $35.7 million (2023), compared with a mean of $26.7 million.
  • Peak annual rise in Capital Leases hit 99.99% in 2024, while the deepest fall reached 99.99% in 2024.
  • Over 4 years, Capital Leases stood at $62.1 million in 2021, then dropped by 21.63% to $48.7 million in 2022, then fell by 26.6% to $35.7 million in 2023, then crashed by 99.99% to $3000.0 in 2024.
  • Business Quant data shows Capital Leases for CORZ at $3000.0 in Q4 2024, $4000.0 in Q3 2024, and $553000.0 in Q2 2024.